What’s one mistake you often see founders make when valuing their startup, and what advice would you give them to avoid it? We’re especially interested in real-world examples: misapplied valuation methods, over-reliance on projections, poor comps, missed dilution effects, or treating pre-revenue hype as value. If you have a go-to framework for choosing the right method (e.g., Berkus vs. DCF vs. comps), feel free to share. Focus on actionable insight founders can apply. Avoid general advice like “be realistic,” generic encouragement, or name-dropping tools without explaining how they help. We want expertise that teaches through experience — especially where art meets science in valuation. Examples from early-stage or angel/seed rounds are especially useful.

posted5/21/2025

deadline6/4/2025

processing

published6/15/2025